Cargando…

Inhibition of the TRAIL Death Receptor by CMV Reveals Its Importance in NK Cell-Mediated Antiviral Defense

TNF-related apoptosis inducing ligand (TRAIL) death receptors (DR) regulate apoptosis and inflammation, but their role in antiviral defense is poorly understood. Cytomegaloviruses (CMV) encode many immune-modulatory genes that shape host immunity, and they utilize multiple strategies to target the T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verma, Shilpi, Loewendorf, Andrea, Wang, Qiao, McDonald, Bryan, Redwood, Alec, Benedict, Chris A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133390/ https://www.ncbi.nlm.nih.gov/pubmed/25122141 http://dx.doi.org/10.1371/journal.ppat.1004268

Ejemplares similares

Human Cytomegalovirus Glycoprotein UL141 Targets the TRAIL Death Receptors to Thwart Host Innate Antiviral Defenses
por: Smith, Wendell, et al.
Publicado: (2013)

N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced death
por: Dufour, Florent, et al.
Publicado: (2017)

Origin of programmed cell death from antiviral defense?
por: Koonin, Eugene V., et al.
Publicado: (2019)

Antiviral Treatment of Maternal and Congenital Cytomegalovirus (CMV) Infections
por: Pinninti, Swetha, et al.
Publicado: (2023)

Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV)
por: Barnes, Samantha, et al.
Publicado: (2020)

CMV reactivation initiates long-term expansion and differentiation of the NK cell repertoire
por: Hassan, Norfarazieda, et al.
Publicado: (2022)

Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients
por: Huntjens, Daan W., et al.
Publicado: (2023)

TRAIL: not just for tumors anymore?
por: Benedict, Chris A., et al.
Publicado: (2012)

Preeclampsia is Characterized by Fetal NK Cell Activation and a Reduction in Regulatory T Cells
por: Loewendorf, Andrea I., et al.
Publicado: (2015)

Successful Use of Heterologous CMV-Reactive T Lymphocyte to Treat Severe Refractory Cytomegalovirus (CMV) Infection in a Liver Transplanted Patient: Correlation of the Host Antiviral Immune Reconstitution with CMV Viral Load and CMV miRNome
por: Miele, Monica, et al.
Publicado: (2021)

Detailed phenotypic and functional characterization of CMV-associated adaptive NK cells in rhesus macaques
por: Hasan, Mohammad Zahidul, et al.
Publicado: (2022)

Delayed NK Cell Reconstitution and Reduced NK Activity Increased the Risks of CMV Disease in Allogeneic-Hematopoietic Stem Cell Transplantation
por: Park, Ki Hyun, et al.
Publicado: (2020)

A Systematic Review and Meta-analysis of Optimized CMV Preemptive Therapy and Antiviral Prophylaxis for CMV Disease Prevention in CMV High-Risk (D+R-) Kidney Transplant Recipients
por: Kumar, Lakshin, et al.
Publicado: (2023)

Antiviral Defense in Invertebrates
por: Flenniken, Michelle L.
Publicado: (2018)

Tissue reservoirs of antiviral T cell immunity in persistent human CMV infection
por: Gordon, Claire L., et al.
Publicado: (2017)

Following the fat trail to death
por: Williams, Ruth
Publicado: (2009)

Ly49P recognition of cytomegalovirus-infected cells expressing H2-D(k) and CMV-encoded m04 correlates with the NK cell antiviral response
por: Kielczewska, Agnieszka, et al.
Publicado: (2009)

NK/ILC1 cells mediate neuroinflammation and brain pathology following congenital CMV infection
por: Kveštak, Daria, et al.
Publicado: (2021)

TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors
por: Mert, Ufuk, et al.
Publicado: (2019)

Structure of Human Cytomegalovirus UL141 Binding to TRAIL-R2 Reveals Novel, Non-canonical Death Receptor Interactions
por: Nemčovičová, Ivana, et al.
Publicado: (2013)

NK Cells in Mucosal Defense against Infection
por: Ivanova, Daria, et al.
Publicado: (2014)

CMV2b-Dependent Regulation of Host Defense Pathways in the Context of Viral Infection
por: Zhao, Jian-Hua, et al.
Publicado: (2018)

Antiviral defense: interferons and beyond
por: Stetson, Daniel B., et al.
Publicado: (2006)

Evolution of viruses and antiviral defense
por: Moelling, Karin
Publicado: (2009)

Lipids in Innate Antiviral Defense
por: Schoggins, John W., et al.
Publicado: (2013)

Dendritic Cells and Antiviral Defense
por: Mailliard, Robbie B.
Publicado: (2020)

The Combination of TRAIL Treatment and Cancer Cell Selective Expression of TRAIL-Death Receptor DR4 Induces Cell Death in TRAIL-Resistant Cancer Cells
por: Choi, Eunah, et al.
Publicado: (2006)

Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen
por: Bates, Matthew, et al.
Publicado: (2016)

Therapeutic targeting of TRAIL death receptors
por: Di Cristofano, Francesca, et al.
Publicado: (2023)

Transplantation-induced cancers: Emerging evidence that clonal CMV-specific NK cells are causal immunogenic factors
por: Achour, Abla, et al.
Publicado: (2014)

Quantifying the Protection of Activating and Inhibiting NK Cell Receptors during Infection with a CMV-Like Virus
por: Carrillo-Bustamante, Paola, et al.
Publicado: (2014)

NK and CD8+ T cell phenotypes predict onset and control of CMV viremia after kidney transplant
por: Pickering, Harry, et al.
Publicado: (2021)

Neutrophils Recruited by IL-22 in Peripheral Tissues Function as TRAIL-Dependent Antiviral Effectors against MCMV
por: Stacey, Maria A., et al.
Publicado: (2014)

Continuous activity of Foxo1 is required to prevent anergy and maintain the memory state of CD8(+) T cells
por: Delpoux, Arnaud, et al.
Publicado: (2018)

The regulation of combined treatment-induced cell death with recombinant TRAIL and bortezomib through TRAIL signaling in TRAIL-resistant cells
por: Ryu, Sunhyo, et al.
Publicado: (2018)

Impact of antiviral treatment on long-term prognosis in non-immunocompromised patients with CMV reactivation
por: Park, Ga Eun, et al.
Publicado: (2021)

NK- and T-cell granzyme B and K expression correlates with age, CMV infection and influenza vaccine-induced antibody titres in older adults
por: Verschoor, Chris P., et al.
Publicado: (2023)

An “Old” protein with a new story: Coronavirus endoribonuclease is important for evading host antiviral defenses
por: Deng, Xufang, et al.
Publicado: (2018)

Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell–mediated deletion
por: Peppa, Dimitra, et al.
Publicado: (2013)

Dengue Virus Induces NK Cell Activation through TRAIL Expression during Infection
por: Gandini, Mariana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9r1cm3gn34aom5j76k86tqgj09